Anthim

Active Ingredient(s): Obiltoxaximab
FDA Approved: * March 18, 2016
Pharm Company: * ELUSYS THERAPEUTICS INC
Category: Antibiotics

Obiltoxaximab, sold under the brand name Anthim, is a monoclonal antibody medication designed for the treatment of exposure to Bacillus anthracis spores (etiologic agent of anthrax).[3][1][4] The medication was developed by Elusys Therapeutics, Inc.[1][5] Contents 1 Medical uses 2 Society and culture 2.1 Legal status 3 References 4 External links Medical uses Obiltoxaximab is indicated in combination wit... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.

Dosage List

Anthim 100 mg/ml Intravenous Solution

NDC: 69604-204

Labeler:

Elusys Therapeutics, Inc.